Hepatitis C treatment appears extremely effective

A mix of four medications has provided the most effective way so far to counter the hepatitis C virus in people with liver scarring.

Twelve weeks after taking the last dose of the treatment, 191 of 208 patients had no trace of the virus in their bloodstream and 165 of 172 patients on a 24-week regimen appeared to be clear of the infection. Researchers reported the results of the phase III clinical trial — the highest standard for getting regulatory approval of a drug — April 12 at the International Liver Conference in London and in the New England Journal of Medicine.

The treatment could be on the market by the end of 2014 or in early 2015, the scientists say.

Ashley Yeager is the associate news editor at Science News. She has worked at The Scientist, the Simons Foundation, Duke University and the W.M. Keck Observatory, and was the web producer for Science News from 2013 to 2015. She has a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content